Para-vertebral Dexmedetomidine and the Incidence of Postoperative Chronic Pain

A

Assiut University

Status

Completed

Conditions

Pain, Postoperative

Treatments

Drug: Dexmedetomidine
Drug: Bupivacaine

Study type

Interventional

Funder types

Other

Identifiers

NCT03632161
IRB00009920

Details and patient eligibility

About

Up to our knowledge there is no study focused upon the incidence of post VATS chronic pain when dexmedetomidine is used.

Full description

Most Video-Assisted Throcoscopy Surgery (VATS) procedures are considered low-risk interventions requiring short hospital stays or even outpatient settings. Because of these factors, VATS did not raise as much interest as thoracotomy in its postoperative pain management. However, it is a fact that pain following VATS can be severe and long-lasting .According to Richardson and colleagues, 38% of VATS procedures present persistent pain two months after surgery as a result of acute nerve damage during the surgical procedure.

Enrollment

60 patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ASA II-III
  • Adult
  • Video-assisted thoracic surgery

Exclusion criteria

  • Patient refusal
  • Allergy to medication
  • Coagulopathy
  • Malformation

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 2 patient groups

Dexmedetomidine
Active Comparator group
Description:
Dexmedetomidine is added to bupivacaine the paravertebral block
Treatment:
Drug: Dexmedetomidine
Bupivacaine
Other group
Description:
Bupivacaine only in the paravertebral block
Treatment:
Drug: Bupivacaine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems